{
  "ticker": "IONS",
  "company_name": "Ionis Pharmaceuticals, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT03548415",
      "title": "Safety, Tolerability, and Efficacy of IONIS-GHR-LRx in Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Acromegaly",
      "start_date": "2018-09-13",
      "completion_date": "2021-04-02",
      "enrollment": 0,
      "sponsor": "Ionis Pharmaceuticals, Inc."
    },
    {
      "nct_id": "NCT05185843",
      "title": "A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRX) Administered to Adults With Familial Chylomicronemia Syndrome (FCS) Previously Treated With Volanesorsen",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "condition": "Familial Chylomicronemia Syndrome",
      "start_date": "2022-02-25",
      "completion_date": "2027-06",
      "enrollment": 0,
      "sponsor": "Ionis Pharmaceuticals, Inc."
    },
    {
      "nct_id": "NCT04030598",
      "title": "A Study to Assess the Clinical Efficacy of Donidalorsen (Also Known as IONIS-PKK-LRx and ISIS 721744) in Participants With Hereditary Angioedema",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Hereditary Angioedema",
      "start_date": "2020-01-07",
      "completion_date": "2021-03-01",
      "enrollment": 0,
      "sponsor": "Ionis Pharmaceuticals, Inc."
    },
    {
      "nct_id": "NCT06153966",
      "title": "PrProfile: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ION717",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Prion Disease",
      "start_date": "2024-01-04",
      "completion_date": "2027-07",
      "enrollment": 0,
      "sponsor": "Ionis Pharmaceuticals, Inc."
    },
    {
      "nct_id": "NCT05667493",
      "title": "An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)",
      "status": "ENROLLING_BY_INVITATION",
      "phase": "PHASE3",
      "condition": "Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)",
      "start_date": "2022-11-30",
      "completion_date": "2029-08",
      "enrollment": 0,
      "sponsor": "Ionis Pharmaceuticals, Inc."
    },
    {
      "nct_id": "NCT00362180",
      "title": "Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Lipid Metabolism, Inborn Errors, Hyperlipidemias, Metabolic Diseases, Hypolipoproteinemia, Hypolipoproteinemias, Hypobetalipoproteinemias, Metabolism, Inborn Errors, Genetic Diseases, Inborn, Infant, Newborn, Diseases, Congenital Abnormalities, Metabolic Disorder, Hypercholesterolemia, Dyslipidemias, Lipid Metabolism Disorders",
      "start_date": "2006-07",
      "completion_date": "2010-09",
      "enrollment": 0,
      "sponsor": "Kastle Therapeutics, LLC"
    },
    {
      "nct_id": "NCT00280995",
      "title": "Dose-escalating Safety Study of ISIS 301012 in Homozygous Familial Hypercholesterolemia Subjects on Lipid Lowering Therapy",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Hypercholesterolemia, Familial",
      "start_date": "2006-01",
      "completion_date": "2007-08",
      "enrollment": 0,
      "sponsor": "Kastle Therapeutics, LLC"
    },
    {
      "nct_id": "NCT00216463",
      "title": "Safety and Tolerability of Varying Load and Dose of ISIS 301012 in People With Elevated LDL-cholesterol Levels",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Hypercholesterolemia",
      "start_date": "2005-08",
      "completion_date": "2007-08",
      "enrollment": 0,
      "sponsor": "Kastle Therapeutics, LLC"
    },
    {
      "nct_id": "NCT02300233",
      "title": "The COMPASS Study: A Study of Volanesorsen (Formally ISIS-APOCIIIRx) in Patients With Hypertriglyceridemia",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Hypertriglyceridemia",
      "start_date": "2015-02-05",
      "completion_date": "2017-01-24",
      "enrollment": 0,
      "sponsor": "Ionis Pharmaceuticals, Inc."
    },
    {
      "nct_id": "NCT04136171",
      "title": "CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "condition": "Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)",
      "start_date": "2020-03-13",
      "completion_date": "2026-08",
      "enrollment": 0,
      "sponsor": "Ionis Pharmaceuticals, Inc."
    }
  ],
  "summary": {
    "total_trials": 50,
    "by_phase": {
      "PHASE2": 14,
      "PHASE3": 11,
      "PHASE1, PHASE2": 4,
      "PHASE1": 14,
      "": 5,
      "PHASE2, PHASE3": 1,
      "NA": 1
    },
    "by_status": {
      "COMPLETED": 35,
      "ACTIVE_NOT_RECRUITING": 6,
      "ENROLLING_BY_INVITATION": 1,
      "TERMINATED": 2,
      "RECRUITING": 4,
      "AVAILABLE": 1,
      "WITHDRAWN": 1
    },
    "active_trials": 11,
    "completed_trials": 35,
    "conditions": [
      "ALS Caused by Superoxide Dismutase 1 (SOD1) Mutation",
      "Abnormalities, Cardiovascular",
      "Acromegaly",
      "Advanced Adult Hepatocellular Carcinoma, Hepatocellular Carcinoma Metastatic",
      "Advanced Cancers, DLBCL, Lymphoma",
      "Alzheimer Disease, Down Syndrome",
      "Amyloidosis, Transthyretin Amyloid Cardiomyopathy",
      "Amyotrophic Lateral Sclerosis",
      "Castrate-Resistant Prostate Cancer",
      "Crohn's Disease",
      "Cytomegalovirus Retinitis, HIV Infections",
      "FAP, Familial Amyloid Polyneuropathy, TTR, Transthyretin, Amyloidosis",
      "Familial Chylomicronemia Syndrome",
      "Familial Chylomicronemia Syndrome, Lipoprotein Lipase Deficiency, Hyperlipoproteinemia Type 1",
      "Familial Partial Lipodystrophy",
      "Geographic Atrophy, Age Related Macular Degeneration",
      "Healthy",
      "Healthy Volunteer",
      "Healthy Volunteers",
      "Hepatic Steatosis",
      "Hereditary Amyloidosis, Transthyretin-Related",
      "Hereditary Angioedema",
      "Heterozygous Familial Hypercholesterolemia, Coronary Artery Disease",
      "Hypercholesterolemia",
      "Hypercholesterolemia, Familial",
      "Hypertension",
      "Hypertriglyceridemia",
      "Hypertriglyceridemia, Familial Hypercholesterolemia",
      "Inflammatory Diseases",
      "Leukodystrophy, White Matter Disease, Leukoencephalopathies, 4H Syndrome, Adrenoleukodystrophy, AMN, ALD, ALD Gene Mutation, ALD (Adrenoleukodystrophy), X-linked Adrenoleukodystrophy, X-ALD, Adrenomyeloneuropathy, Aicardi Goutieres Syndrome, AGS, Alexander Disease, Alexanders Leukodystrophy, AxD, ADLD, Canavan Disease, CTX, Cerebrotendinous Xanthomatoses, Krabbe Disease, GALC Deficiency, Globoid Leukodystrophy, TUBB4A-Related Leukodystrophy, H-ABC - Hypomyelination, Atrophy of Basal Ganglia and Cerebellum, HBSL, HBSL - Hypomyelination, Brain Stem, Spinal Cord, Leg Spasticity, LBSL, Leukoencephalopathy With Brain Stem and Spinal Cord Involvement and High Lactate Syndrome (Disorder), Leukoencephalopathy With Brainstem and Spinal Cord Involvement and Lactate Elevation, ALSP, CSF1R Gene Mutation, HCC - Hypomyelination and Congenital Cataract, MLC1, Megalencephalic Leukoencephalopathy With Subcortical Cysts, MLD, Metachromatic Leukodystrophy, PMD, Pelizaeus-Merzbacher Disease, PLP1 Null Syndrome, PLP1 Gene Duplication &#X7C; Blood or Tissue &#X7C; Mutations, Pelizaeus Merzbacher Like Disease, Peroxisomal Biogenesis Disorder, Zellweger Syndrome, Refsum Disease, Salla Disease, Sialic Storage Disease, Sj\u00f6gren, Sjogren-Larsson Syndrome, Van Der Knapp Disease, Vanishing White Matter Disease, Charcot-Marie-Tooth, CMT, Mct8 (Slc16A2)-Specific Thyroid Hormone Cell Transporter Deficiency, Allan-Herndon-Dudley Syndrome, Cadasil, Cockayne Syndrome, Multiple Sulfatase Deficiency, Gangliosidoses, GM2 Gangliosidosis, BPAN, Labrune Syndrome, LCC, Mucopolysaccharidoses, TBCK-Related Intellectual Disability Syndrome",
      "Lipid Metabolism, Inborn Errors, Hyperlipidemias, Metabolic Diseases, Hypolipoproteinemia, Hypolipoproteinemias, Hypobetalipoproteinemias, Metabolism, Inborn Errors, Genetic Diseases, Inborn, Infant, Newborn, Diseases, Congenital Abnormalities, Metabolic Disorder, Hypercholesterolemia, Dyslipidemias, Lipid Metabolism Disorders",
      "Lung Cancer",
      "Macular Degeneration, Geographic Atrophy",
      "Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome",
      "Multiple System Atrophy",
      "Paroxysmal Atrial Fibrillation",
      "Pelizaeus-Merzbacher Disease",
      "Prion Disease",
      "Renal Impairment",
      "Rheumatoid Arthritis",
      "Thalassemia",
      "Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)",
      "Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)",
      "Ulcerative Colitis"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-12T09:33:09.491907",
    "search_query": "Ionis Pharmaceuticals, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Ionis+Pharmaceuticals,+Inc."
  }
}